CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,948 | +125.8% | 181,625 | +84.4% | 0.06% | +235.3% |
| Q2 2023 | $2,191 | -45.1% | 98,476 | -46.5% | 0.02% | -63.0% |
| Q1 2023 | $3,988 | +1344.9% | 184,096 | +1253.1% | 0.05% | +1433.3% |
| Q4 2022 | $276 | -99.9% | 13,605 | +0.1% | 0.00% | -25.0% |
| Q3 2022 | $348,000 | -59.9% | 13,592 | -62.8% | 0.00% | -55.6% |
| Q2 2022 | $868,000 | -94.6% | 36,513 | -94.9% | 0.01% | -92.4% |
| Q1 2022 | $16,128,000 | +182.9% | 716,183 | +148.8% | 0.12% | +280.6% |
| Q4 2021 | $5,700,000 | +226.3% | 287,860 | +224.3% | 0.03% | +287.5% |
| Q3 2021 | $1,747,000 | +1488.2% | 88,765 | +1674.2% | 0.01% | +700.0% |
| Q2 2021 | $110,000 | -70.4% | 5,003 | -68.0% | 0.00% | -50.0% |
| Q1 2021 | $372,000 | -88.0% | 15,625 | -86.8% | 0.00% | -88.2% |
| Q4 2020 | $3,104,000 | -31.7% | 118,672 | -54.5% | 0.02% | -41.4% |
| Q3 2020 | $4,543,000 | +6.7% | 261,037 | +3.1% | 0.03% | -17.1% |
| Q2 2020 | $4,258,000 | +96.9% | 253,158 | +39.2% | 0.04% | +75.0% |
| Q1 2020 | $2,162,000 | +244.8% | 181,857 | +250.8% | 0.02% | +233.3% |
| Q4 2019 | $627,000 | +224.9% | 51,839 | +279.0% | 0.01% | +200.0% |
| Q3 2019 | $193,000 | +82.1% | 13,679 | +44.0% | 0.00% | +100.0% |
| Q2 2019 | $106,000 | -23.2% | 9,497 | -18.9% | 0.00% | 0.0% |
| Q1 2019 | $138,000 | -94.1% | 11,715 | -93.3% | 0.00% | -95.2% |
| Q4 2018 | $2,348,000 | +2115.1% | 175,779 | +2215.6% | 0.02% | +2000.0% |
| Q3 2018 | $106,000 | -69.3% | 7,591 | -65.4% | 0.00% | -66.7% |
| Q2 2018 | $345,000 | +216.5% | 21,941 | +137.1% | 0.00% | +200.0% |
| Q2 2017 | $109,000 | -73.5% | 9,255 | -75.3% | 0.00% | -75.0% |
| Q1 2017 | $411,000 | +170.4% | 37,533 | +79.6% | 0.00% | +300.0% |
| Q4 2016 | $152,000 | +100.0% | 20,901 | -26.5% | 0.00% | – |
| Q3 2014 | $76,000 | +68.9% | 28,419 | +76.5% | 0.00% | – |
| Q2 2014 | $45,000 | – | 16,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |